Background: Evaluation of mass drug administration (MDA) is done internally by the health authorities and externally by independent agencies. This paper reports the findings of evaluation of MDA conducted independently for Government of India in Yadgir district of Karnataka state in February 2011 by the authors. Objective: To assess the Coverage & Compliance rates of MDA against lymphatic filariasis and to study the factors influencing non-coverage and non-compliance in Yadgir district. Materials and Methods: A Community based cross-sectional study was conducted in three randomly selected villages and one urban ward. The data was collected in a pre-designed semistructured proforma from 200 households. Pregnant women, children <2 years and severely ill were excluded from the study. Results: 1026 eligible population were studied and 51.07% of them were males. The Diethylcarbamazine citrate plus Albendazole coverage rate was 97.36% and the compliance rate was 77.77%. The major reason for non-compliance was due to fear of side effects amounting to 58%. Only 4 persons reported adverse effects after drug consumption. Conclusion: A high level of motivation and commitment from the drug distributors with adequate training is required for ensuring a high coverage and compliance rates.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.